Current concepts and management of glioblastoma (Q37904921)

25 August 2017

1 reference

title

Current concepts and management of glioblastoma (English)

1 reference

25 August 2017

Sandrine De Ribaupierre

Sandrine de Ribaupierre

2

0 references

Adelheid Wöhrer

Adelheid Wöhrer

3

0 references

Monika E Hegi

Monika Hegi

5

0 references

Matthias Preusser

Matthias Preusser

1

0 references

Michael Weller

6

Michael Weller

1 reference

25 August 2017

Sara C Erridge

4

1 reference

PubMed ID

21786296

25 August 2017

Roger Stupp

7

1 reference

25 August 2017

1 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

70

1 reference

25 August 2017

9-21

1 reference

25 August 2017

1

1 reference

An integrated genomic analysis of human glioblastoma multiforme

25 August 2017

1 reference

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

21 January 2018

1 reference

Epidemiology and etiology of gliomas

21 January 2018

1 reference

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

Mobile phone use and risk of glioma in 5 North European countries

21 January 2018

1 reference

Cellular-telephone use and brain tumors

21 January 2018

1 reference

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

21 January 2018

1 reference

Genome-wide association study identifies five susceptibility loci for glioma

21 January 2018

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

21 January 2018

1 reference

Signaling in malignant astrocytomas: role of neural stem cells and its therapeutic implications.

21 January 2018

1 reference

Identification of human brain tumour initiating cells

21 January 2018

1 reference

21 January 2018

1 reference

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

21 January 2018

1 reference

Genetic alterations and signaling pathways in the evolution of gliomas

21 January 2018

1 reference

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

21 January 2018

1 reference

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

Distinct role of macrophages in different tumor microenvironments

21 January 2018

1 reference

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

21 January 2018

1 reference

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

21 January 2018

1 reference

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

Operative techniques for gliomas and the value of extent of resection

21 January 2018

1 reference

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

21 January 2018

1 reference

Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial

21 January 2018

1 reference

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).

21 January 2018

1 reference

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

21 January 2018

1 reference

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

Radiotherapy for glioblastoma in the elderly.

21 January 2018

1 reference

Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme.

21 January 2018

1 reference

Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.

21 January 2018

1 reference

Rechallenge with temozolomide in patients with recurrent gliomas

21 January 2018

1 reference

Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach

21 January 2018

1 reference

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.

21 January 2018

1 reference

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

21 January 2018

1 reference

Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

21 January 2018

1 reference

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

21 January 2018

1 reference

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.

21 January 2018

1 reference

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

21 January 2018

1 reference

Bevacizumab does not increase the risk of remote relapse in malignant glioma.

21 January 2018

1 reference

Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab.

21 January 2018

1 reference

Radiographic patterns of relapse in glioblastoma.

21 January 2018

1 reference

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

21 January 2018

1 reference

Glioblastoma multiforme: a review of where we have been and where we are going

21 January 2018

1 reference

New molecular targets in malignant gliomas

21 January 2018

1 reference

Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma

21 January 2018

1 reference

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

21 January 2018

1 reference

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study

21 January 2018

1 reference

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide

21 January 2018

1 reference

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

21 January 2018

1 reference

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

21 January 2018

1 reference

Molecularly targeted therapies for glioma

21 January 2018

1 reference

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

21 January 2018

1 reference

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma

21 January 2018

1 reference

A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme

21 January 2018

1 reference

Integrin alphavbeta3-targeted radioimmunotherapy of glioblastoma multiforme

21 January 2018

1 reference

Patterns of care for adults with newly diagnosed malignant glioma.

21 January 2018

1 reference

Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group.

21 January 2018

1 reference

Epilepsy in cerebral glioma: timing of appearance and histological correlations.

21 January 2018

1 reference

Antiepileptic drugs for preventing seizures in people with brain tumors

21 January 2018

1 reference

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

21 January 2018

1 reference

Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis

21 January 2018

1 reference

Antiepileptic drug monotherapy: the initial approach in epilepsy management

21 January 2018

1 reference

The management of brain edema in brain tumors

21 January 2018

1 reference

The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

21 January 2018

1 reference

The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review

21 January 2018

1 reference

Venous thromboembolism and survival in patients with high-grade glioma

21 January 2018

1 reference

Management of venous thromboembolism in patients with primary and metastatic brain tumors

21 January 2018

1 reference

Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.

21 January 2018

1 reference

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

21 January 2018

1 reference

Psychosocial and supportive-care needs in high-grade glioma

21 January 2018

1 reference

The end-of-life hospital setting in patients with glioblastoma

21 January 2018

1 reference

End of life issues in brain tumor patients.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.22425

1 reference

release_tcga3vsxhzanhg2zlgq3iray2a

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tcga3vsxhzanhg2zlgq3iray2a

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21786296

1 reference

PubMed ID

21786296